Brisou, G., Paillassa, J., Bernard, S., Tournilhac, O., Fornecker, L., Maloisel, F., . . . Herbaux, C. Clinical benefit of tafasitamab plus lenalidomide in relapsed or refractory diffuse large Bcell lymphoma: Real-world data from the EarlyMIND study. Ferrata Storti Foundation.
Chicago Style (17th ed.) CitationBrisou, Gabriel, et al. Clinical Benefit of Tafasitamab Plus Lenalidomide in Relapsed or Refractory Diffuse Large Bcell Lymphoma: Real-world Data from the EarlyMIND Study. Ferrata Storti Foundation.
MLA (9th ed.) CitationBrisou, Gabriel, et al. Clinical Benefit of Tafasitamab Plus Lenalidomide in Relapsed or Refractory Diffuse Large Bcell Lymphoma: Real-world Data from the EarlyMIND Study. Ferrata Storti Foundation.
Warning: These citations may not always be 100% accurate.